Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Jun 15, 2024; 16(6): 2380-2393
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2380
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2380
Figure 1 A simplified scheme for the hepatic artery infusion chemotherapy prediction strategy.
Prognostic factors influencing hepatic arterial infusion chemotherapy for hepatocellular carcinoma, Such as biomarkers, imaging, and genomics. HAIC: Hepatic arterial infusion chemotherapy; NLR: Neutrophil to lymphocyte ratio; DCP: Des-γ-carboxy prothrombin; AFP: Alpha-fetoprotein; VEGF: Vascular endothelial growth factor; VWF: Willebrand factor; ADC: Apparent diffusion coefficient; IL-28B: Interleukin-28B.
- Citation: Wang QF, Li ZW, Zhou HF, Zhu KZ, Wang YJ, Wang YQ, Zhang YW. Predicting the prognosis of hepatic arterial infusion chemotherapy in hepatocellular carcinoma. World J Gastrointest Oncol 2024; 16(6): 2380-2393
- URL: https://www.wjgnet.com/1948-5204/full/v16/i6/2380.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i6.2380